🔎 Trials Near Me

Home › Ovarian Epithelial Carcinoma › California › San Diego

Ovarian Epithelial Carcinoma clinical trials in San Diego, CA

7 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

RecruitingObservational study
  • University of California, San Diego, La Jolla · 11 mi away
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

RecruitingPhase 3
  • Research Site, La Jolla · 11 mi away
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

RecruitingPhase 3
  • Scripps Clinic, La Jolla · 11 mi away
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

RecruitingPhase 1
  • Moores Cancer Center UC San Diego Health, La Jolla · 11 mi away
Ages 18 and older · All sexes · Updated Aug 15, 2025 · NCT04429542

A Beta-only IL-2 ImmunoTherapY Study

RecruitingPhase 1/2
  • Sharp Memorial Hospital, San Diego
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

RecruitingPhase 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi away
Ages 18 and older · All sexes · Updated Feb 8, 2024 · NCT04282044

Ovarian Epithelial Carcinoma trials in other cities

Other studies in San Diego

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.